Literature DB >> 23709498

A case of cluster headache treated with rotigotine: clinical and neurophysiological correlates.

Cherubino Di Lorenzo1, Gianluca Coppola, Francesco Pierelli.   

Abstract

BACKGROUND: Chronic cluster headache (CCH) is characterized by recurrent bouts of facial pain lasting up to 180 minutes in the absence of a long remission period. CASE: We report the case of a 43-year-old male patient with treatment-resistant CCH, who improved with administration of transdermal rotigotine. We also evaluated the nociceptive blink reflex habituation that was reduced before the treatment (as is usual in CH patients) and normalized by transdermal rotigotine.
CONCLUSIONS: We suggest that rotigotine could represent a further therapeutic option in the treatment of drug-resistant CCH.

Entities:  

Keywords:  Cluster headache; blink reflex; dopamine agonist; habituation; prophylaxis; rotigotine

Mesh:

Substances:

Year:  2013        PMID: 23709498     DOI: 10.1177/0333102413490346

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  4 in total

1.  Cognitive processing of cluster headache patients: evidence from event-related potentials.

Authors:  Rongfei Wang; Zhao Dong; Xiaoyan Chen; Ruozhuo Liu; Mingjie Zhang; Jinglong Wu; Shengyuan Yu
Journal:  J Headache Pain       Date:  2014-10-02       Impact factor: 7.277

Review 2.  Habituation and sensitization in primary headaches.

Authors:  Gianluca Coppola; Cherubino Di Lorenzo; Jean Schoenen; Francesco Pierelli
Journal:  J Headache Pain       Date:  2013-07-30       Impact factor: 7.277

3.  Propofol and alfentanil in treatment of a patient with episodic cluster headache.

Authors:  Sajjad Razavi; Babak Gharaei; Alireza Jafari; Homayoun Aghamohammadi; Alireza Mirkheshti
Journal:  Anesth Pain Med       Date:  2014-05-03

4.  Efficacy of Modified Atkins Ketogenic Diet in Chronic Cluster Headache: An Open-Label, Single-Arm, Clinical Trial.

Authors:  Cherubino Di Lorenzo; Gianluca Coppola; Davide Di Lenola; Maurizio Evangelista; Giulio Sirianni; Paolo Rossi; Giorgio Di Lorenzo; Mariano Serrao; Francesco Pierelli
Journal:  Front Neurol       Date:  2018-02-12       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.